Barclays’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-110,018
| Closed | -$8.28M | – | 4990 |
|
|
2022
Q2 | $8.28M | Buy |
110,018
+66,042
| +150% | +$4.97M | 0.01% | 888 |
|
|
2022
Q1 | $1.18M | Sell |
43,976
-48,109
| -52% | -$1.29M | ﹤0.01% | 2182 |
|
|
2021
Q4 | $4.39M | Buy |
92,085
+71,727
| +352% | +$3.42M | ﹤0.01% | 1324 |
|
|
2021
Q3 | $1.35M | Buy |
20,358
+13,395
| +192% | +$890K | ﹤0.01% | 2086 |
|
|
2021
Q2 | $544K | Sell |
6,963
-35,925
| -84% | -$2.81M | ﹤0.01% | 2440 |
|
|
2021
Q1 | $4.06M | Buy |
42,888
+29,163
| +212% | +$2.76M | ﹤0.01% | 1346 |
|
|
2020
Q4 | $1.67M | Sell |
13,725
-3,394
| -20% | -$413K | ﹤0.01% | 1687 |
|
|
2020
Q3 | $1.5M | Sell |
17,119
-4,300
| -20% | -$376K | ﹤0.01% | 1681 |
|
|
2020
Q2 | $1.38M | Buy |
21,419
+7,040
| +49% | +$455K | ﹤0.01% | 1718 |
|
|
2020
Q1 | $641K | Sell |
14,379
-13,916
| -49% | -$620K | ﹤0.01% | 1995 |
|
|
2019
Q4 | $1.76M | Buy |
28,295
+24,303
| +609% | +$1.51M | ﹤0.01% | 1969 |
|
|
2019
Q3 | $150K | Sell |
3,992
-289
| -7% | -$10.9K | ﹤0.01% | 3187 |
|
|
2019
Q2 | $174K | Buy |
+4,281
| New | +$174K | ﹤0.01% | 3284 |
|